Fingerprint
Dive into the research topics of 'Phase I study of DMOT4039A, an antibody-drug conjugate targeting mesothelin, in patients with unresectable pancreatic or platinum-resistant ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically